Christina Weiler-Normann
Dr. med.
Christina Weiler-Normann
  • Fachärztin für Innere Medizin
  • 1.Arbeitsbereich
Sprachen
Deutsch (Muttersprache)
Englisch
Schwedisch

Fachgebiete

Tätigkeitsschwerpunkte

Lebenslauf

Publikationen

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
Vor

Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study
Uhlenbusch N, Löwe B, Härter M, Schramm C, Weiler-Normann C, Depping M
PLOS ONE. 2019;14(2):e0211343.

CEACAM1 controls IL-2-dependent regulatory T cell induction in immune-mediated hepatitis
Horst A, Wegscheid C, Schaefers C, Schiller B, Neumann K, Lunemann S, Langeneckert A, Oldhafer K, Weiler-Normann C, Lang K, Singer B, Altfeld M, Diehl L, Tiegs G
HEPATOLOGY. 2018;68(1):200-214.

Efficacy and Limitations of Budesonide as a Second-line Treatment for Patients With Autoimmune Hepatitis
Peiseler M, Liebscher T, Sebode M, Zenouzi R, Hartl J, Ehlken H, Pannicke N, Weiler-Normann C, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2018;16(2):260-267.e1.

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
Peiseler M, Reiners D, Pinnschmidt H, Sebode M, Jung F, Hartl J, Zenouzi R, Ehlken H, Groth S, Schachschal G, Rösch T, Weiler-Normann C, Lohse A, Schramm C
PLOS ONE. 2018;13(8):.

Immunosuppression as effective therapy for eosinophilic cholangiopathy: A case series and review of the literature
Reher D, Schramm C, Brinkert F, Weidemann S, Plauth M, Lohse A, Weiler-Normann C
GastroHep. 2018;1(1):33-44.

Immunosuppression as efficient therapy for Eosinophilic Cholangitis: A case series and review of the literature
Reher D, Schramm C, Brinkert F, Weidemann S, Plauth M, Lohse A, Weiler-Normann C
2018. Zeitschrift für Gastroenterologie. 01. Aufl. Georg Thieme Verlag KG, E2-E89.

Autoimmune Hepatitis
Sanyal A, Boyer T, Lindor K, Terrault N, Lohse A, Weiler-Normann C
2018. Zakim and Boyer's Hepatology. 7. Aufl. Philadelphia: Elsevier, .

Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance
Sebode M, Weiler-Normann C, Liwinski T, Schramm C
FRONT IMMUNOL. 2018;9:609.

Acute hepatitis as a prequel to very severe aplastic anemia
Weiler-Normann C, Hartl J, Weidemann S, von Pein U, Fiedler W, Schramm C, Brinkert F, Kröger N, Christopeit M
Z GASTROENTEROL. 2018;56(1):51-54.

Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
Zenouzi R, Liwinski T, Yamamura J, Weiler-Normann C, Sebode M, Keller S, Lohse A, Schramm C
ALIMENT PHARM THER. 2018;48(2):169-178.

Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure
Zenouzi R, von der Gablentz J, Heldmann M, Göttlich M, Weiler-Normann C, Sebode M, Ehlken H, Hartl J, Fellbrich A, Siemonsen S, Schramm C, Münte T, Lohse A
PLOS ONE. 2018;13(1):e0190005.

Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis
Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, von Felden J, Weiler-Normann C, Schramm C, Lohse A
J HEPATOL. 2017 [Epub ahead of print].

Correction: Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography
Löbel U, Forkert N, Schmitt C, Dohrmann T, Schroeder M, Magnus T, Kluge S, Weiler-Normann C, Bi X, Fiehler J, Sedlacik J
PLOS ONE. 2017;12(2):e0172450.

Can Understanding the Pathogenesis of Autoimmune Hepatitis Lead to Rational Therapy?
Lohse A, Herkel J, Weiler-Normann C
DIGEST DIS. 2017;35(4):367-370.

Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study
Peiseler M, Creutzfeldt A, Cassens I, Glaubke C, Kroll C, Lohse A, Weiler-Normann C
Z GASTROENTEROL. 2017;55(8):754-760.

CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood
Schoknecht T, Schwinge D, Stein S, Weiler-Normann C, Sebode M, Mucha S, Otto B, Ellinghaus E, Stahl F, Franke A, Lohse A, Herkel J, Schramm C
J LEUKOCYTE BIOL. 2017;101(2):589-597.

Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
Ehlken H, Wroblewski R, Corpechot C, Arrivé L, Rieger T, Hartl J, Lezius S, Hübener P, Schulze K, Zenouzi R, Sebode M, Peiseler M, Denzer U, Quaas A, Weiler-Normann C, Lohse A, Chazouilleres O, Schramm C
PLOS ONE. 2016;11(10):e0164224.

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis
Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse A, Schramm C
J HEPATOL. 2016;65(4):769-75.

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
Hübener S, Oo Y, Than N, Hübener P, Weiler-Normann C, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(3):445-453.

Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography
Löbel U, Forkert N, Schmitt P, Dohrmann T, Schroeder M, Magnus T, Kluge S, Weiler-Normann C, Bi X, Fiehler J, Sedlacik J
PLOS ONE. 2016;11(11):e0164863.

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy
Than N, Wiegard C, Weiler-Normann C, Füssel K, Mann J, Hodson J, Hirschfield G, Lohse A, Adams D, Schramm C, Oo Y
SCAND J GASTROENTERO. 2016;51(3):329-336.

The role of the multidisciplinary health care team in the management of patients with Marfan syndrome
von Kodolitsch Y, Rybczynski M, Vogler M, Mir T, Schüler H, Kutsche K, Rosenberger G, Detter C, Bernhardt A, Larena-Avellaneda A, Kölbel T, Debus E, Schroeder M, Linke S, Fuisting B, Napp B, Kammal A, Püschel K, Bannas P, Hoffmann B, Gessler N, Vahle-Hinz E, Kahl-Nieke B, Thomalla G, Weiler-Normann C, Ohm G, Neumann S, Benninghoven D, Blankenberg S, Pyeritz R
J Multidiscip Healthc. 2016;9:587-614.

Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
Weiler-Normann C, Lohse A
DIGEST DIS SCI. 2016;61(9):2462 - 64.

Variant Syndromes of Autoimmune Liver Diseases: Classification, Diagnosis and Management
Weiler-Normann C, Lohse A
DIGEST DIS. 2016;34(4):334-9.

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
Zenouzi R, Weismüller T, Jørgensen K, Bubenheim M, Lenzen H, Hübener P, Schulze K, Weiler-Normann C, Sebode M, Ehlken H, Pannicke N, Hartl J, Peiseler M, Hübener S, Karlsen T, Boberg K, Manns M, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(12):1806-1812.

Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis
Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse A, Schramm C
J HEPATOL. 2015;62(3):642-6.

Phenotypic alterations of regulatory T cells in autoimmune hepatitis: causal or associated with treatment and remission?
Sebode M, Peiseler M, Weiler-Normann C, Schramm C, Lohse A, Herkel J
HEPATOLOGY. 2015;61(2):736-37.

Phenotypic alterations of regulatory T cells in autoimmune Hepatitis causal or associated with treatment and remission?
Sebode M, Peiseler M, Weiler-Normann C, Schramm C, Lohse A, Herkel J
HEPATOLOGY. 2015;61(2):736-7.

Primary biliary "cirrhosis" time to replace a misnomer
Wahl I, Feige A, Löwe B, Weiler-Normann C, Rose M, Lohse A, Schramm C
HEPATOLOGY. 2015;61(3):1091.

Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature
Beisel C, Weiler-Normann C, Teufel A, Lohse A
WORLD J GASTROENTERO. 2014;20(35):12662-12667.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1
de Boer Y, van Gerven N, Zwiers A, Verwer B, van Hoek B, van Erpecum K, Beuers U, van Buuren H, Drenth J, den Ouden J, Verdonk R, Koek G, Brouwer J, Guichelaar M, Vrolijk J, Kraal G, Mulder C, van Nieuwkerk C, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse A, Weiler-Normann C, Lerch M, Nauck M, Völzke H, Homuth G, Bloemena E, Verspaget H, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G
GASTROENTEROLOGY. 2014;147(2):443-452.

Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse A, Rose M
J HEPATOL. 2014;60(3):618-624.

Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, Quaas A, Petersen B, Ellinghaus E, Baron U, Olek S, Wiegard C, Weiler-Normann C, Lohse A, Herkel J, Schramm C
J HEPATOL. 2014;60(5):1010-6.

Reply to: "Anti-TNF-induced autoimmune hepatitis"
Weiler-Normann C, Herkel J, Schramm C, Lohse A
J HEPATOL. 2014;61(1):170-171.

Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis
Zenouzi R, Weismüller T, Hübener P, Schulze K, Bubenheim M, Pannicke N, Weiler-Normann C, Lenzen H, Manns M, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2014.

Not all PBC is the same!
Lohse A, Weiler-Normann C
GASTROENTEROLOGY. 2013;144(3):494-7.

Autoimmune hepatitis: a life-long disease.
Weiler-Normann C, Lohse A
J HEPATOL. 2013;58(1):5-7.

Reply to: "Use of TNFα antagonists in refractory AIH: revealing the unforeseen"
Weiler-Normann C, Schramm C, Lohse A
J HEPATOL. 2013;59(1):198-9.

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.
Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Hübener S, Lohse A
J HEPATOL. 2013;58(3):529-534.

Autoimmune hepatitis 2013 and beyond
Weiler-Normann C, Sebode M, Lohse A
Minerva Gastroenterol Dietol. 2013;59(2):133-41.

Is fatigue in primary biliary cirrhosis cured by transplantation?
Zenouzi R, Weiler-Normann C, Lohse A
J HEPATOL. 2013;59(3):418-9.

Acute liver failure following minocycline treatment - a case report and review of the literature.
Kuhn A, Weiler-Normann C, Schramm C, Kluge S, Behne M, Lohse A, Benten D
Z GASTROENTEROL. 2012;50(8):771-775.

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse A, Weiler-Normann C, Schramm C, Herkel J
J HEPATOL. 2012;57(1):125-32.

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse A, Weiler-Normann C, Schramm C, Herkel J
J HEPATOL. 2012;57(1):125-132.

Treatment adherence - room for improvement, not only in autoimmune hepatitis.
Weiler-Normann C, Lohse A
J HEPATOL. 2012;57(6):1168-1170.

Drug induced liver injury and its relationship to autoimmune hepatitis.
Weiler-Normann C, Schramm C
J HEPATOL. 2011;55(4):747-749.

Immune-mediated liver injury.
Lohse A, Weiler-Normann C, Tiegs G
J HEPATOL. 2010;52:136-144.

Treatment response in patients with autoimmune hepatitis.
Schramm C, Weiler-Normann C, Wiegard C, Hellweg S, Müller S, Lohse A
HEPATOLOGY. 2010;52(6):2247-2248.

[Autoimmune liver diseases]
Lüth S, Weiler-Normann C, Schramm C, Lohse A
INTERNIST. 2009;50(3):310-317.

Autoimmunerkrankungen der Leber
Lüth S, Weiler-Normann C, Schramm C, Lohse A
INTERNIST. 2009;50(3):310-7.

A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
Weiler-Normann C, Wiegard C, Schramm C, Lohse A
AM J GASTROENTEROL. 2009;104(11):2877-2878.

Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.
Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin E, Herkel J, David C, Lohse A, Rehermann B
GASTROENTEROLOGY. 2008;135(6):2107-2118.

Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV.
Mizukoshi E, Eisenbach C, Edlin B, Newton K, Raghuraman S, Weiler-Normann C, Tobler L, Busch M, Carrington M, McKeating J, O'Brien T, Rehermann B
J INFECT DIS. 2008;198(2):203-212.

De novo autoimmune hepatitis after liver transplantation.
Lohse A, Weiler-Normann C, Burdelski M
HEPATOL RES. 2007;37(3):462.

Mouse models of liver fibrosis.
Weiler-Normann C, Herkel J, Lohse A
Z GASTROENTEROL. 2007;45(1):43-50.

Letzte Aktualisierung aus dem FIS: 17.07.2019 - 00:33 Uhr